2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine

C83H101N19O4S4 — CID 157267065

IUPAC2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine
SMILESCCOCc1sc(-c2ccnc(Nc3cc(C)cc(C)c3)n2)nc1C.COCc1sc(-c2ccnc(Nc3cc(C)cc(C)c3)n2)nc1C.Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(CN4CCCC(CO)C4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(CN4CCN(CCO)CC4)s3)n2)c1
InChIInChI=1S/C23H30N6OS.C23H29N5OS.C19H22N4OS.C18H20N4OS/c1-16-12-17(2)14-19(13-16)26-23-24-5-4-20(27-23)22-25-18(3)21(31-22)15-29-8-6-28(7-9-29)10-11-30;1-15-9-16(2)11-19(10-15)26-23-24-7-6-20(27-23)22-25-17(3)21(30-22)13-28-8-4-5-18(12-28)14-29;1-5-24-11-17-14(4)21-18(25-17)16-6-7-20-19(23-16)22-15-9-12(2)8-13(3)10-15;1-11-7-12(2)9-14(8-11)21-18-19-6-5-15(22-18)17-20-13(3)16(24-17)10-23-4/h4-5,12-14,30H,6-11,15H2,1-3H3,(H,24,26,27);6-7,9-11,18,29H,4-5,8,12-14H2,1-3H3,(H,24,26,27);6-10H,5,11H2,1-4H3,(H,20,22,23);5-9H,10H2,1-4H3,(H,19,21,22)
InChIKeyAYCPTDQEHAJSSH-UHFFFAOYSA-N
MW1557.12 g/mol
LogP17.07
Rot. Bonds24

About 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine

2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine (PubChem CID 157267065) has the molecular formula C83H101N19O4S4 and a molecular weight of 1557.12 g/mol. Its IUPAC name is 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine.

Molecular Properties

Compound Name2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine
PubChem CID157267065
Molecular FormulaC83H101N19O4S4
Molecular Weight1557.12 g/mol
Exact Mass1555.72
IUPAC Name2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine
SMILESCCOCc1sc(-c2ccnc(Nc3cc(C)cc(C)c3)n2)nc1C.COCc1sc(-c2ccnc(Nc3cc(C)cc(C)c3)n2)nc1C.Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(CN4CCCC(CO)C4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(CN4CCN(CCO)CC4)s3)n2)c1
InChIInChI=1S/C23H30N6OS.C23H29N5OS.C19H22N4OS.C18H20N4OS/c1-16-12-17(2)14-19(13-16)26-23-24-5-4-20(27-23)22-25-18(3)21(31-22)15-29-8-6-28(7-9-29)10-11-30;1-15-9-16(2)11-19(10-15)26-23-24-7-6-20(27-23)22-25-17(3)21(30-22)13-28-8-4-5-18(12-28)14-29;1-5-24-11-17-14(4)21-18(25-17)16-6-7-20-19(23-16)22-15-9-12(2)8-13(3)10-15;1-11-7-12(2)9-14(8-11)21-18-19-6-5-15(22-18)17-20-13(3)16(24-17)10-23-4/h4-5,12-14,30H,6-11,15H2,1-3H3,(H,24,26,27);6-7,9-11,18,29H,4-5,8,12-14H2,1-3H3,(H,24,26,27);6-10H,5,11H2,1-4H3,(H,20,22,23);5-9H,10H2,1-4H3,(H,19,21,22)
InChIKeyAYCPTDQEHAJSSH-UHFFFAOYSA-N
XLogP17.07
TPSA271.44 Ų
H-Bond Donors6
H-Bond Acceptors27
Rotatable Bonds24
Heavy Atoms110
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001557.12
LogP ≤ 517.07
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1027

Analyze 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine?
The IUPAC name of 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine (CID 157267065) is 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine.
What is the SMILES notation for 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine?
The canonical SMILES for 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine is CCOCc1sc(-c2ccnc(Nc3cc(C)cc(C)c3)n2)nc1C.COCc1sc(-c2ccnc(Nc3cc(C)cc(C)c3)n2)nc1C.Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(CN4CCCC(CO)C4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3nc(C)c(CN4CCN(CCO)CC4)s3)n2)c1.
What is the InChIKey of 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine?
The InChIKey is AYCPTDQEHAJSSH-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H30N6OS.C23H29N5OS.C19H22N4OS.C18H20N4OS/c1-16-12-17(2)14-19(13-16)26-23-24-5-4-20(27-23)22-25-18(3)21(31-22)15-29-8-6-28(7-9-29)10-11-30;1-15-9-16(2)11-19(10-15)26-23-24-7-6-20(27-23)22-25-17(3)21(30-22)13-28-8-4-5-18(12-28)14-29;1-5-24-11-17-14(4)21-18(25-17)16-6-7-20-19(23-16)22-15-9-12(2)8-13(3)10-15;1-11-7-12(2)9-14(8-11)21-18-19-6-5-15(22-18)17-20-13(3)16(24-17)10-23-4/h4-5,12-14,30H,6-11,15H2,1-3H3,(H,24,26,27);6-7,9-11,18,29H,4-5,8,12-14H2,1-3H3,(H,24,26,27);6-10H,5,11H2,1-4H3,(H,20,22,23);5-9H,10H2,1-4H3,(H,19,21,22).
What are the key properties of 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine?
2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine has a molecular weight of 1557.12 g/mol, XLogP of 17.07, 24 rotatable bonds, 6 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperazin-1-yl]ethanol;[1-[[2-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-5-yl]methyl]piperidin-3-yl]methanol;N-(3,5-dimethylphenyl)-4-[5-(ethoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(methoxymethyl)-4-methyl-1,3-thiazol-2-yl]pyrimidin-2-amine is sourced from PubChem (CID 157267065), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).